Related Experiment Video
Updated: Dec 10, 2025

09:34
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
2.1K
Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis
Rodrigo Abreu1, Pramod Giri1, Fred Quinn1
1Department of Infectious Diseases, University of Georgia, Athens, GA, United States.
Frontiers in Immunology
|August 28, 2020
Summary
Tuberculosis treatment faces challenges from drug resistance and side effects. Host-directed therapies targeting host-pathogen interactions offer a promising new strategy against Mycobacterium tuberculosis.
Area of Science:
- Microbiology and Immunology
- Evolutionary Biology
- Infectious Diseases
Background:
- Tuberculosis (TB), caused by *Mycobacterium tuberculosis*, remains a leading infectious cause of death globally.
- Current multi-drug treatments are lengthy, have significant side effects, and face increasing drug resistance (MDR-TB, XDR-TB).
- Host-pathogen co-evolution has shaped TB pathogenesis and outcomes over millennia.
Purpose of the Study:
- To review host-pathogen interactions during *Mycobacterium tuberculosis* infection.
- To describe immune evasion mechanisms employed by *M. tuberculosis*.
- To discuss current host-directed therapies (HDTs) targeting these interactions.
Main Methods:
- Review of scientific literature on host-pathogen interactions in TB.
- Analysis of *M. tuberculosis* immune modulation and evasion strategies.
- Evaluation of existing and emerging host-directed therapeutic approaches.
Main Results:
- *M. tuberculosis* actively modulates host immune responses to promote bacterial growth and survival.
- Understanding evolutionary host-pathogen dynamics is key to developing novel therapeutics.
- Host-directed therapies show promise in enhancing bacterial clearance and complementing existing anti-TB drugs.
Conclusions:
- Host-directed therapies represent a vital addition to the TB treatment arsenal.
- Targeting host-pathogen interactions can overcome limitations of conventional anti-mycobacterial drugs.
- Further research into these interactions will guide the rational design of effective new TB treatments.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis II
1.1K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.1K
Defense Against Bacterial Pathogens
2.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.4K
Pulmonary Tuberculosis V
376
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
376
Pulmonary Tuberculosis I
625
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
625
Pulmonary Tuberculosis IV
332
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
332
Pulmonary Tuberculosis III
705
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
705

